Doctors in Japan can again prescribe an Amgen rare-disease drug to new patients, reversing a recommendation made only days ago following 20 deaths
5 days ago
4
The Japanese drugmaker that sells rare-disease medicine Tavneos said caller patients volition beryllium capable to get the drug, which carries hazard of liver injury.